Wall Street’s consensus among 25 analysts surveyed by S&P Global assigns Palantir Technologies a hold rating, with just four recommending a buy. The average 12-month price target implies only low single-digit upside from current levels, reflecting concerns that the stock’s forward price-to-earnings multiple of roughly 175x already embeds several years of growth expectations. After a 135% rally in 2025, analysts caution that diminishing near-term catalysts could leave Palantir’s momentum largely exhausted in 2026.

Palantir delivered revenue growth exceeding 30% year-over-year in its most recent quarter, backed by an 80.8% gross margin and an industry-leading Rule of 40 score of 114%. New customer wins spanned both government and commercial sectors, yet the company’s forward price-earnings-to-growth ratio of 2.9 stands in stark contrast to more moderately valued peers. Investors must weigh Palantir’s robust top-line expansion against a valuation that demands sustained high-growth execution.

Recent disclosures reveal that Rep. Jonathan Jackson purchased between $15,001 and $50,000 worth of Palantir shares in late December 2025, a move drawing attention due to his role on the House Foreign Affairs Committee and Palantir’s deep ties to defense contracts. The transaction follows earlier scrutiny of former Rep. Marjorie Taylor Greene’s timing of Palantir purchases ahead of major government deals. Such trades have fueled debate over legislators trading stock in companies directly affected by their committee assignments.